TD Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

TD Asset Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-116,890	Closed	-$15.9M	–	1506
2020 Q3	$15.9M	Buy	116,890 +42,100	+56%	+$4.48M	0.02%	440
2020 Q2	$7.23M	Buy	74,790 +12,204	+19%	+$1.02M	0.01%	581
2020 Q1	$2.93M	Sell	62,586 -4,000	-6%	-$256K	0.01%	741
2019 Q4	$4.85M	Hold	66,586	–	–	0.01%	714
2019 Q3	$3.47M	Buy	66,586 +3,004	+5%	+$160K	0.01%	772
2019 Q2	$3.19M	Buy	63,582 +500	+0.8%	+$24.3K	﹤0.01%	801
2019 Q1	$3.28M	Buy	63,082 +18,085	+40%	+$833K	0.01%	793
2018 Q4	$2.2M	Sell	44,997 -1,200	-3%	-$66.1K	﹤0.01%	892
2018 Q3	$3.01M	Buy	46,197 +8,100	+21%	+$476K	﹤0.01%	886
2018 Q2	$1.89M	Buy	38,097 +7,097	+23%	+$344K	﹤0.01%	976
2018 Q1	$1.51M	Buy	31,000 +13,571	+78%	+$705K	﹤0.01%	958
2017 Q4	$734K	Buy	17,429 +8,929	+105%	+$344K	﹤0.01%	1123
2017 Q3	$364K	Buy	+8,500	New	+$271K	﹤0.01%	1209

TD Asset Management's MYOK Position: Q4 2020 in Review

TD Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 116,890 shares — an estimated $15.9M sold.

TD Asset Management first reported a position in MYOK in Q3 2017 and held it in 13 quarters. The position peaked at $15.9M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

TD Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
TD Asset Management sold 116,890 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $15.9M.
TD Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 13 quarters.
TD Asset Management's MyoKardia, Inc. Common Stock position peaked at $15.9M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on TD Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.